Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement.
D000328:Adult; D000368:Aged; D001178:Arthroplasty; D002986:Clinical Trials as Topic; D003911:Dextrans / Q000008:administration & dosage; D005260:Female; D005268:Femoral Vein; D005340:Fibrinogen; D006493:Heparin / Q000008:administration & dosage* / Q000627:therapeutic use; D006615:Hip / Q000601:surgery*; D006801:Humans; D007279:Injections, Subcutaneous; D007457:Iodine Radioisotopes; D007595:Joint Prosthesis; D008297:Male; D008875:Middle Aged; D010690:Phlebography; D011182:Postoperative Care; D011300:Preoperative Care; D011446:Prospective Studies; D011877:Radionuclide Imaging; D013924:Thrombophlebitis / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000517:prevention & control*; D013997:Time Factors
D003911:Dextrans; D007457:Iodine Radioisotopes; D005340:Fibrinogen; D006493:Heparin